InMode Without Vasculaze Operator Manual
Section 8: Lumecca Treatment
Information
Section 8: Lumecca Treatment Information
IPL Lumecca treatment is based on principles of selective photothermolysis. The light
penetrates into the skin and is selectively absorbed by lesion chromophore (melanin
or hemoglobin) having darker color than surrounding tissue. Absorbed energy is
converted into heat, coagulating the lesion which fades during a few weeks following
the treatment. Fine textural lesions like macro-pores, and fine lines may improve
along with the pigmented and vascular lesions in the skin photo-rejuvenation
process. Multiple treatment sessions may be required for best results.
Instructions for Use
The Lumecca Handpieces are intended for treatment of superficial vascular and
pigmented lesions on skin type I to IV.
Contraindications
Current or history of skin cancer, or current condition of any other type of cancer, or
pre-malignant moles.
Pregnancy and nursing.
Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or
use of immunosuppressive medications.
Patients with history of diseases stimulated by heat, such as recurrent Herpes Simplex
in the treatment area, may be treated only following a prophylactic regimen.
Severe concurrent conditions, such as cardiac disorders, sensory disturbances.
Any active condition in the treatment area, such as sores, psoriasis, eczema, and rash.
History of skin disorders, keloids, abnormal wound healing, as well as very dry and
fragile skin.
Poorly controlled endocrine disorders, such as diabetes or thyroid dysfunction and
hormonal virilization.
Use of Isotretinoin (Accutane®) within 6 months prior to treatment.
Certain delay is recommended if other recent treatments such as light, laser or RF
were performed on treated area.
Known skin photosensitivity or using drugs increasing skin photosensitivity.
Diseases that may be stimulated by light, such as epilepsy, lupus and urticaria.
To Next Page
Loading...